Smith Julie
- SEC CIK
- 0001557928
In the past year, 1 open-market sale filing worth $4.69M and no purchases.
Current role at each company
- STOK Stoke Therapeutics, Inc.Directoras of Jun 5, 2026
- EXEL Exelixis, Inc.Directoras of May 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $4.69M
- 1 filing
- Net
- −$4.69M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Julie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXEL Exelixis, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2024 (view filing) | May 21 | 2 days | Smith JulieDirector | SSale | −27.3K | $21.12 | −$576.2K | −83.4%5.45K after | |
| Feb 28, 2025 (view filing) | Feb 27-28 | 1 day | Smith JulieDirector | SSale | −73.8K | $38.00 | −$2.80M | −87.3%10.8K after | 2 lots |
| Feb 19, 2026 (view filing) | Feb 17-18 | 2 days | Smith JulieDirector | SSale | −106.5K | $44.00 | −$4.69M | −83.8%20.6K after | 3 lots |